Plan Snapshot
- Plan Sponsor: Crispr Therapeutics, INC.
- Sponsor EIN: 473173478
- Sponsor Address: 105 W. FIRST ST., BOSTON, MA, 02127
- Plan Type: 401(k)
- Total Participants: 398
- Total Assets: $66.7M
Key Plan Design Features
- Auto-Enrollment: Yes
- Auto-Escalation: No
- Allows Roth Contributions: Yes
- Participant Loans: No
- Participant-Directed Investments: Yes
- ERISA Section 404(c) Fiduciary Safe Harbor: Yes
Plan Financials by Year
| Year | Participants | Total Assets | Employer Contrib. | Employee Contrib. |
|---|---|---|---|---|
| 2024 | 398 | $66.7M | $2.6M | $6.2M |
| 2023 | 399 | $53.8M | $2.9M | $6.8M |
| 2022 | 449 | $37.6M | $3.7M | $6.8M |
Service Providers (Schedule C)
Vendors paid $5,000 or more for services to the plan, ranked by total compensation (direct + indirect fees).
| Provider Name | Role | Direct Compensation | Indirect Compensation | Total Fees |
|---|---|---|---|---|
| BAKER NEWMAN NOYES | Auditor | — | — | $0 |
Plan Fees & Expenses
Annual service provider fees and administrative expenses sourced from DOL Form 5500 filings.
- Total Service Provider Fees: $0
Historical Administrative Expenses
Breakdown of administrative expense categories reported on Form 5500 filings.
| Year | Total Admin Expenses | Investment Mgmt Fees | Contract Admin Fees | IQPA Audit Fees | Professional Fees |
|---|---|---|---|---|---|
| 2024 | -$99,382 | $23,595 | — | — | — |
| 2023 | -$72,843 | $18,134 | — | — | — |
| 2022 | -$52,540 | $14,909 | — | — | — |